|
|
Article: Oncolab: Cancer Immune: Via the First Human General Cancer Antibody.
- Article from:
- Business Wire
- Article date:
- November 8, 1999
CopyrightCOPYRIGHT 1999 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BOSTON--(BW HealthWire)--Nov. 5, 1999--
Evidence of a Universal Immune Response by the Body to Cancer,
Patent Granted, and First Synthetic General
Cancer Vaccine Developed
See www.cancerimmune.com, www.antimaligninantibody.com &
www.amascancertest.com.
The first direct evidence in substantial human populations of a universal immune defense against human cancer was just presented to the American Association for Cancer Research. 3 laboratories studied 8,090 people. Antimalignin antibody in serum (AMAS) was shown to be a specific Immunosurveillant(TM) which is cytotoxic to cancer cells, regardless of cell type. ...